The single family office of Tom Baruch was founded in 2012. Tom is a well-known American business man and venture capitalist. For example, he was one of the founding partners of the famous venture capital funds CEMEA Capital and Formation 8, a technology investment firm based in Silicon Valley with a presence in Korea, Singapore and China.
Baruch Future Ventures focuses on early and seed investments in companies that are active in resource scarce and climate sensitive markets. Target areas spread broadly across all verticals in the resource technology space - Energy, Air & Water Quality, and Food & Agriculture with special focus on clean energy, healthcare and biotech investments. One example is ?BiomX?, a microbiome company developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectal cancer, as well as bacteria that affect the appearance of the skin.
Tom Baruch currently invests in early stage companies focused on resource scarce and climate sensitive markets out of his family office, Baruch Future Ventures (BFV). Tom founded Formation 8 in 2011, a venture capital fund with $950 million under management and currently serves as an Emeritus Partner. Tom earlier formed CMEA Capital in 1988 with New Enterprise Associates (NEA) and 3M Corp. Tom was responsible for managing a total of $1.2 billion of capital across seven funds at CMEA where he personally led investments resulting in 18 IPO?s including, Aclara Biosciences, Codexis, Inc., CNano Technologies, Flextronics, Inc., Intermolecular, and Symyx Technologies, and 8 M&A transactions including Silicon Spice, acquired by Broadcom (BRCM). 10 of Tom?s successful portfolio exits were at market capitalizations of greater than $1 billion (?unicorn category).
Tom Baruch的单一家族办公室成立于2012年。汤姆是美国著名的商人和风险投资家。例如,他是著名风险投资基金CEMEA capital and Formation 8的创始合伙人之一,这是一家位于硅谷的技术投资公司,在韩国、新加坡和中国都有业务。
Baruch Future Ventures专注于对活跃于资源稀缺和气候敏感市场的公司进行早期和种子投资。目标领域广泛分布在资源技术领域的所有垂直领域——能源、空气和水质、食品和农业,特别关注清洁能源、医疗保健和生物技术投资。一个例子是BiomX?这家微生物组公司开发定制噬菌体疗法,旨在针对并摧毁慢性疾病(如炎症性肠病和结肠直肠癌)中的有害细菌,以及影响皮肤外观的细菌。
汤姆•巴鲁克(Tom Baruch)目前投资于他的家族公司Baruch Future Ventures (BFV)的早期公司,这些公司专注于资源稀缺和气候敏感市场。汤姆于2011年创立了风险投资基金Formation 8,管理资金9.5亿美元,目前是其荣誉合伙人。汤姆于1988年与新企业协会(New Enterprise Associates)和3M corp共同成立了CMEA Capital。汤姆在CMEA负责管理7个基金共计12亿美元的资金。包括Aclara Biosciences、Codexis, Inc.、cannano Technologies、Flextronics, Inc.、Intermolecular和Symyx Technologies,以及8宗并购交易,包括被Broadcom收购的Silicon Spice。10的汤姆?美国成功退出投资组合时,其市值超过10亿美元。类别)。
资产规模:
950mm USD
950百万美金
交易结构:
Private Equity,Venture Capital,Long-term Investments,Seed Capital
私募股权,风险资本,长期投资,种子资本
交易规模:
5 mm - 200mm
5百万-200百万美金
投资细分赛道:
Biotechnology,Green Energy,Emerging Technology,Wealth & Estate Planning,Alternative Energy,Startups & Management,Artificial Intelligence,Data Processing & Outsourced Services
生物技术、绿色能源、新兴技术、财富与遗产规划、替代能源、创业与管理、人工智能、数据处理与外包服务
投资产业方向:
Life Sciences,Pharmaceuticals,Diversified Financial Services,Independent Power and Renewable Electricity Producers,Biotechnology,Alternative Investments,Software,IT Services
产业集群:
Financials,Energy,Utilities,Healthcare,Information Technology
投资区域:
Asia/pacific,United States